System and method for diagnosis and treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9114147
APP PUB NO 20140107086A1
SERIAL NO

14100714

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy utilizing a GCR antagonist, such as ORG 34517. The rapid, sensitive, and inexpensive test can be used to determine patients who have non-normal cortisol production or disordered circadian rhythms as a method for selecting subjects for GCR antagonist therapy for whom it is likely to have beneficial and/or therapeutic effects, and can also be used to monitor changes in cortisol levels in response to treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POP TEST ONCOLOGY LIMITED LIABILITY COMPANY36 CECELIA AVENUE CLIFFSIDE PARK NJ 07010

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Altschul, Randice Lisa Cliffside Park, US 56 568
O'Brien, Rebecca Shell Knob, US 54 528
Rapkin, Myron Indianapolis, US 57 549
Theise, Neil David New York, US 49 525

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00